1,187
Views
6
CrossRef citations to date
0
Altmetric
Articles

Effects of Notch signalling pathway on the relationship between vascular endothelial dysfunction and endothelial stromal transformation in atherosclerosis

&
Pages 764-772 | Received 04 May 2017, Accepted 29 May 2017, Published online: 16 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Siti Sarah Azman, Muhammad Dain Yazid, Nur Azurah Abdul Ghani, Raja Zahratul Azma Raja Sabudin, Mohd Ramzisham Abdul Rahman & Nadiah Sulaiman. (2023) Generation of a novel ex-vivo model to study re-endothelialization. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 408-416.
Read now

Articles from other publishers (5)

Weijie Wang, Yilan Li, Yanxiu Zhang, Tao Ye, Kui Wang, Shuijie Li & Yao Zhang. (2023) SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1. Cardiovascular Diabetology 22:1.
Crossref
Jin-Wen Luo, Yuan Hu, Jian Liu, Huan Yang & Peng Huang. (2021) Interleukin-22: a potential therapeutic target in atherosclerosis. Molecular Medicine 27:1.
Crossref
Dingjun Sun, Tianyi Ma, Yixue Zhang, Fuwei Zhang & Bo Cui. (2020) Overexpressed miR‐335‐5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome. Journal of Clinical Laboratory Analysis 35:2.
Crossref
Yilong Pan, Linlin Wang, Yaofeng Xie, Yuan Tan, Cheng Chang, Xueshan Qiu & Xiaodong Li. (2020) Characterization of differentially expressed plasma proteins in patients with acute myocardial infarction. Journal of Proteomics 227, pages 103923.
Crossref
Cheng-Gen Zheng, Bing-Yu Chen, Ren-Hua Sun, Xiao-Zhou Mou, Fang Han, Qian Li, Hai-Jun Huang, Jing-Quan Liu & Yue-Xing Tu. (2019) miR-133b Downregulation Reduces Vulnerable Plaque Formation in Mice with AS through Inhibiting Macrophage Immune Responses. Molecular Therapy - Nucleic Acids 16, pages 745-757.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.